loading

Finanzdaten der Aligos Therapeutics Inc-Aktie (ALGS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
210.29%
0.965
0.311 0.606 1.25 1.061
Operating Expenses
0.11%
19.53
19.55 21.19 21.40 27.48
Benefits Costs and Expenses
138.87%
16.64
-42.82 82.73 20.42 -4.189
Costs And Expenses
138.87%
16.64
-42.82 82.73 20.42 -4.189
Provision For Loan, Lease, And Other Losses
-
- - - -
Operating Income/Loss
3.51%
-18.57
-19.24 -20.56 -20.13 -26.41
Net Interest Income/Expense
50.00%
0.40
0.80 0.30 0.50 0.30
Interest Income/Expense After Provision For Losses
50.00%
0.40
0.80 0.30 0.50 0.30
Income/Loss From Continuing Operations Before Tax
136.35%
-15.68
43.13 -82.12 -19.17 5.25
Income Tax Expense/Benefit
330.23%
0.185
0.043 0.027 0.091 0.189
Income/Loss From Continuing Operations After Tax
136.82%
-15.86
43.09 -82.15 -19.26 5.061
Net Income/Loss
136.82%
-15.86
43.09 -82.15 -19.26 5.061
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
23.10%
10.35
8.4085 0.00591 6.2723 156.44
Diluted Average Shares
18.85%
10.35
8.7097 0.00591 6.2723 156.65
Basic Earnings Per Share
129.88%
-1.53
5.12 -13.10 -3.07 0.03
Diluted Earnings Per Share
27.49%
-1.53
-2.11 -13.10 -3.07 0.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.41
price down icon 1.33%
$86.71
price up icon 0.64%
$26.12
price up icon 1.02%
$110.44
price down icon 0.73%
$131.69
price up icon 1.75%
biotechnology ONC
$313.67
price up icon 1.48%
Kapitalisierung:     |  Volumen (24h):